サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1411704

デジタルバイオマニュファクチャリング市場：展開、用途、最終用途別-2024～2030年の世界予測

Digital Biomanufacturing Market by Deployment (Cloud, On-premises), Application (Antibodies, Cell & Gene Therapies, Proteins), End-use - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 188 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
デジタルバイオマニュファクチャリング市場：展開、用途、最終用途別-2024～2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 188 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

デジタルバイオマニュファクチャリング市場規模は2023年に173億5,000万米ドルと推定され、2024年には189億7,000万米ドルに達すると予測され、CAGR 9.67％で2030年には331億2,000万米ドルに達すると予測されます。

デジタルバイオマニュファクチャリングの世界市場

主要市場の統計
基準年[2023年] 173億5,000万米ドル
予測年[2024年] 189億7,000万米ドル
予測年[2030年] 331億2,000万米ドル
CAGR（%） 9.67%
デジタルバイオマニュファクチャリング Market-IMG1

FPNVポジショニングマトリックス

FPNVポジショニングマトリックスはデジタルバイオマニュファクチャリング市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます。フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、デジタルバイオマニュファクチャリング市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発とイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-デジタルバイオマニュファクチャリング市場の市場規模と予測は？

2-デジタルバイオマニュファクチャリング市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-デジタルバイオマニュファクチャリング市場における技術動向と規制の枠組みは？

4-デジタルバイオマニュファクチャリング市場における主要ベンダーの市場シェアは？

5-デジタルバイオマニュファクチャリング市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • デジタルバイオマニュファクチャリングプロセスの重要な用途
      • 生物製剤の需要の増加とバイオ製造プロセスの強化の必要性
      • バイオ製造施設の稼働拡大
    • 抑制要因
      • デジタルバイオマニュファクチャリング技術の導入には高額なコストが必要
    • 機会
      • バイオ製造におけるビッグデータとデジタルツインの新たな役割
      • スマートファクトリー開発に対する政府の取り組みと投資の拡大
    • 課題
      • デジタルバイオマニュファクチャリングに関連する移行とサイバーセキュリティの課題
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 デジタルバイオマニュファクチャリング市場：展開別

  • イントロダクション
  • クラウド
  • オンプレミス

第7章 デジタルバイオマニュファクチャリング市場：用途別

  • イントロダクション
  • 抗体
  • 細胞と遺伝子治療
  • タンパク質
  • ワクチン

第8章 デジタルバイオマニュファクチャリング市場：最終用途別

  • イントロダクション
  • 学術研究機関
  • バイオ医薬品企業
  • 受託研究機関

第9章 南北アメリカのデジタルバイオマニュファクチャリング市場

  • イントロダクション
  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋のデジタルバイオマニュファクチャリング市場

  • イントロダクション
  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカのデジタルバイオマニュファクチャリング市場

  • イントロダクション
  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第13章 競合ポートフォリオ

  • 主要な企業プロファイル
    • 3M Company
    • ABB Ltd.
    • Agilent Technologies, Inc.
    • bioMerieux SA
    • Bota Biosciences, Ltd.
    • CellPort Software
    • Culture Biosciences, Inc.
    • Cytiva（Global Life Sciences Solutions USA LLC）
    • Debut Biotechnology
    • Donaldson Company, Inc.
    • Emerson Electric Co.
    • FabricNano
    • GE Healthcare
    • Indegene Limited
    • OVO Biomanufacturing
    • Samsung Biologics
    • Sanofi SA
    • Sartorius AG
    • Shimadzu Corp.
    • Siemens AG
    • Thermo Fisher Scientific Inc.
    • Waters Corp.
    • 64xBio
  • 主要な製品ポートフォリオ

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. DIGITAL BIOMANUFACTURING MARKET RESEARCH PROCESS
  • FIGURE 2. DIGITAL BIOMANUFACTURING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. DIGITAL BIOMANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. DIGITAL BIOMANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. DIGITAL BIOMANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. DIGITAL BIOMANUFACTURING MARKET DYNAMICS
  • FIGURE 7. DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2023 VS 2030 (%)
  • FIGURE 8. DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 12. DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. DIGITAL BIOMANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. DIGITAL BIOMANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. DIGITAL BIOMANUFACTURING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. DIGITAL BIOMANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 6. DIGITAL BIOMANUFACTURING MARKET SIZE, BY CLOUD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. DIGITAL BIOMANUFACTURING MARKET SIZE, BY ON-PREMISES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 9. DIGITAL BIOMANUFACTURING MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL & GENE THERAPIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROTEINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. DIGITAL BIOMANUFACTURING MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 14. DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. DIGITAL BIOMANUFACTURING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 144. DIGITAL BIOMANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 145. DIGITAL BIOMANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. DIGITAL BIOMANUFACTURING MARKET LICENSE & PRICING
目次
Product Code: MRR-5C6F41F5AF52

[188 Pages Report] The Digital Biomanufacturing Market size was estimated at USD 17.35 billion in 2023 and expected to reach USD 18.97 billion in 2024, at a CAGR 9.67% to reach USD 33.12 billion by 2030.

Global Digital Biomanufacturing Market

KEY MARKET STATISTICS
Base Year [2023] USD 17.35 billion
Estimated Year [2024] USD 18.97 billion
Forecast Year [2030] USD 33.12 billion
CAGR (%) 9.67%
Digital Biomanufacturing Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Digital Biomanufacturing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Digital Biomanufacturing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Digital Biomanufacturing Market, highlighting leading vendors and their innovative profiles. These include 3M Company, ABB Ltd., Agilent Technologies, Inc., bioMerieux SA, Bota Biosciences, Ltd., CellPort Software, Culture Biosciences, Inc., Cytiva (Global Life Sciences Solutions USA LLC), Debut Biotechnology, Donaldson Company, Inc., Emerson Electric Co., FabricNano, GE Healthcare, Indegene Limited, OVO Biomanufacturing, Samsung Biologics, Sanofi SA, Sartorius AG, Shimadzu Corp., Siemens AG, Thermo Fisher Scientific Inc., Waters Corp., and 64xBio.

Market Segmentation & Coverage

This research report categorizes the Digital Biomanufacturing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Deployment
    • Cloud
    • On-premises
  • Application
    • Antibodies
    • Cell & Gene Therapies
    • Proteins
    • Vaccines
  • End-use
    • Academic & Research Institutes
    • Biopharmaceutical Companies
    • Contract Research Organizations
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Digital Biomanufacturing Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Digital Biomanufacturing Market?

3. What are the technology trends and regulatory frameworks in the Digital Biomanufacturing Market?

4. What is the market share of the leading vendors in the Digital Biomanufacturing Market?

5. Which modes and strategic moves are suitable for entering the Digital Biomanufacturing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Digital Biomanufacturing Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Significant applications of the digital biomanufacturing process
      • 5.1.1.2. Increased demand for biologics and need for enhanced biomanufacturing process
      • 5.1.1.3. Expanding operations of biomanufacturing facilities
    • 5.1.2. Restraints
      • 5.1.2.1. High costs required for the deployment of digital biomanufacturing technologies
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging roles of big data and digital twin in biomanufacturing
      • 5.1.3.2. Growing government initiatives and investments in smart factory development
    • 5.1.4. Challenges
      • 5.1.4.1. Transition and cybersecurity challenges associated with digital biomanufacturing
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Digital Biomanufacturing Market, by Deployment

  • 6.1. Introduction
  • 6.2. Cloud
  • 6.3. On-premises

7. Digital Biomanufacturing Market, by Application

  • 7.1. Introduction
  • 7.2. Antibodies
  • 7.3. Cell & Gene Therapies
  • 7.4. Proteins
  • 7.5. Vaccines

8. Digital Biomanufacturing Market, by End-use

  • 8.1. Introduction
  • 8.2. Academic & Research Institutes
  • 8.3. Biopharmaceutical Companies
  • 8.4. Contract Research Organizations

9. Americas Digital Biomanufacturing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Digital Biomanufacturing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Digital Biomanufacturing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. 3M Company
    • 13.1.2. ABB Ltd.
    • 13.1.3. Agilent Technologies, Inc.
    • 13.1.4. bioMerieux SA
    • 13.1.5. Bota Biosciences, Ltd.
    • 13.1.6. CellPort Software
    • 13.1.7. Culture Biosciences, Inc.
    • 13.1.8. Cytiva (Global Life Sciences Solutions USA LLC)
    • 13.1.9. Debut Biotechnology
    • 13.1.10. Donaldson Company, Inc.
    • 13.1.11. Emerson Electric Co.
    • 13.1.12. FabricNano
    • 13.1.13. GE Healthcare
    • 13.1.14. Indegene Limited
    • 13.1.15. OVO Biomanufacturing
    • 13.1.16. Samsung Biologics
    • 13.1.17. Sanofi SA
    • 13.1.18. Sartorius AG
    • 13.1.19. Shimadzu Corp.
    • 13.1.20. Siemens AG
    • 13.1.21. Thermo Fisher Scientific Inc.
    • 13.1.22. Waters Corp.
    • 13.1.23. 64xBio
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing